MLchartDataset catalogue

huC242-DM4

Term · Oncology and biomedicine · MLC-T-ONC-003998

A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called maytansinoid DM4-conjugated humanized monoclonal antibody huC242.

Table 1. Record
IdentifierMLC-T-ONC-003998
FieldOncology and biomedicine
Expansionsmaytansinoid DM4-conjugated humanized monoclonal antibody huC242
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003998",
  "term": "huC242-DM4",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. It is made by linking the monoclonal antibody huC242 to a toxic substance called maytansinoid DM4. The monoclonal antibody binds to the surfaces of cancer cells and the maytansinoid DM4 enters the cells and blocks their growth. It is a type of immunotoxin. Also called maytansinoid DM4-conjugated humanized monoclonal antibody huC242.",
  "expansions": [
    "maytansinoid DM4-conjugated humanized monoclonal antibody huC242"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/huc242-dm4/"
}

Record 8,722 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.